Member Info for Laura2022

This is what I've been saying since well before Feb 2026 and at 1.2p :)

Now 200% nearly since connwnt below

Laura2022

Posts: 16,115

Price: 1.20

No Opinion

RE: Boost for rare earths25 Jan 2026 09:19

For REE its also the strategic Gallium

Which is now over $2060 which has increased 1000% over 10yrs

As of Jan 2026

Rationale: YTD momentum (+~32%) plus constrained Western gallium availability post-ban keeps support under prices; CRMA execution and U.S. “critical” designation buoy sentiment even if volumes lag.

Has has had huge success on KEN as a TR1 holders there for 12mths ( 0.3p to 2p)

Shrwed mole

Totally agree

Fantastic re rate

Gallium the hidden gem *see posts early January)

Thanks frankie

Decent buying

Over 60% of market capitalisation in cash

At least 3 funds have increased

Director have bought

Fda clearance soon

Addressable Market of $1 trillion

Someone else wanted an EXTRA £550,000 shares recently

Chart breakout due above 1.3p

Good rns

Today should be the day everything clears

My Friday buys looking timely

Looks like all holders holding firm and with that 2mln buy above 6p Friday it should be good day

The recent accounts are a good starting point as is the recent statements from the company

Okenurst has made some good observations over the weekend

Hope that helps ?

Also since youve been away a holder called Mr Dixon ias acquired 20% of SBTX

Good morning

When did you hold if your don't mind me.asking as there's nothing on your timeline ?

As for cash runway , £2.9mln is about 1.5-2yrs of run way if you look at annual results

In complete agreement

I am juat shy of 500k at under 6p average

Kendal

Almost all of his last 7 weeks of nonsense has been "groundless" , still doesn't make sense for him to just appear on SPI and hold/comment on no other shares

Excellent summary from Okehurst yesterday morning

SBTX has vertical integration model that is genuinely compelling on paper:

∙ Zenakine IP licensed to Croda (global specialty chemicals giant) → royalty stream

∙ AxisBiotix own-brand supplements → direct margin

∙ Dermatonics → NHS/pharmacy distribution channel + established revenue

∙ BTS → in-house manufacturing capability → margin control

∙ Superdrug deal → mass market retail access

Maybe missed by some that they are projecting a 27% increase in full year revenues , which given below ( year end June 2025) would mean just over £1mln for 2025/26

(2025) Total income (revenue and grant income) increased 46% to £834,156 

Straight

You've had 2 weeks off

Amd added nothing:)

This could be one of the best opportunities to make significant gains in 2026 due to these unfortunate events

Earlier posts this morning summarise succinctly the value proposition here ,

Added to that :

1) charts most oversold ever

2) a 2mln buyer

3) the ability to buy may well be more difficult next week

The Board is confident, however, in the underlying financial health of the business due to its ROBUST cash position (£2.92m as at 13 February 2026).

Whilst the Board believes this is an ISOLATED incident,

Roxi

Do as I suggested

He'll be gone by Monday

Easy

Everyone email

Info@lse.co.uk

And report these people